| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/26/2012 | US20120021047 Id-1 Gene and Gene Products as Therapeutic Targets for Treatment of Breast Cancer and Other Types of Carcinoma |
| 01/26/2012 | US20120021046 Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods |
| 01/26/2012 | US20120021045 Methods for Inhibiting Cancer Cell Proliferation |
| 01/26/2012 | US20120021044 Novel Cationic Lipid, A Preparation Method of the Same and A Delivery System Comprising the Same |
| 01/26/2012 | US20120021043 Nucleic Acids Comprising formula (NuGlXmGnNv)a and Derivatives Thereof as Immunostimulating Agent/Adjuvant |
| 01/26/2012 | US20120021042 Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances |
| 01/26/2012 | US20120021041 Transdermal delivery |
| 01/26/2012 | US20120021038 Coating composition |
| 01/26/2012 | US20120021037 Medical devices with an activated coating |
| 01/26/2012 | US20120021036 Composite nanostructures and methods for making and using them |
| 01/26/2012 | US20120021035 Nanoparticles containing plymeric nucleic acid homologs, pharmaceutical composition and articles of manufacture containing same and methods of use thereof |
| 01/26/2012 | US20120021033 DISPERSIN B POLYNUCLEOTIDES AND METHODS OF PRODUCING RECOMBINANT DspB POLYPEPTIDES |
| 01/26/2012 | US20120021029 Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions |
| 01/26/2012 | US20120021026 Dissolvable Fibrous Web Structure Article Comprising Active Agents |
| 01/26/2012 | US20120021024 Delivery system for active components as part of an edible composition background of the invention |
| 01/26/2012 | US20120021021 Method for preparing pharmaceutical compositions comprising fine particles of active substance |
| 01/26/2012 | US20120021020 Branched amphipathic oligo-peptides that self-assemble into vesicles |
| 01/26/2012 | US20120021019 Cardiac stem cell populations for repair of cardiac tissue |
| 01/26/2012 | US20120021018 Microspheres for the sustained release of octreotide with a low initial burst |
| 01/26/2012 | US20120021017 N-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 01/26/2012 | US20120021016 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 01/26/2012 | US20120021015 Crosslinked fibers and method of making same using uv radiation |
| 01/26/2012 | US20120021014 Corrosion current-generating metal particulates and use thereof |
| 01/26/2012 | US20120021013 Composition Containing Sulfoalkyl Ether Cyclodextrin and Latanoprost |
| 01/26/2012 | US20120021012 Novel pharmaceutical uses for nanoparticles |
| 01/26/2012 | US20120021011 Anti-inflammatory pharmaceutical composition comprising extracts from broussonetia papyrifera and lonicera japonica |
| 01/26/2012 | US20120021010 Antiplatelet agent and methods of using the same |
| 01/26/2012 | US20120021009 Process for making gastroretentive dosage forms |
| 01/26/2012 | US20120021008 Injectable and moldable ceramic materials |
| 01/26/2012 | US20120020895 Bear bile macromolecular extract and preparation method and use thereof |
| 01/26/2012 | US20120020887 Use of Simple Amino Acids to Form Porous Particles |
| 01/26/2012 | US20120020879 Process, composition and method for anion deposition into ferritin for therapeutic and other use |
| 01/26/2012 | US20120020877 Process and intra-cervical device for the local release of drugs in the local-regional treatment of cervical cancer |
| 01/26/2012 | US20120020833 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 01/26/2012 | US20120017924 Coated nicotine-containing chewing gum, manufacture and use thereof |
| 01/26/2012 | US20120017892 Use of salt of an acetylsalicylic acid for the treatment of viral infections |
| 01/26/2012 | CA2817959A1 Improved apparatus and process for making soft gel capsules |
| 01/26/2012 | CA2806476A1 Substituted indoles, antiviral active component, method for producing and using same |
| 01/26/2012 | CA2806260A1 Tacrolimus-containing oil-in-water type creamy composition |
| 01/26/2012 | CA2806183A1 Transdermal adhesive compositions, devices, and methods |
| 01/26/2012 | CA2806076A1 Anti-tumor antigen antibodies and methods of use |
| 01/26/2012 | CA2806069A1 Methods of intravenous administration of glyburide and other drugs |
| 01/26/2012 | CA2806051A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anticancer agent, method for producing and using same |
| 01/26/2012 | CA2805980A1 Combination of siloxane and active ingredient for treating dental disorder |
| 01/26/2012 | CA2805753A1 Therapeutic protein compositions having reduced immunogenicity and/or improved efficacy |
| 01/26/2012 | CA2805745A1 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| 01/26/2012 | CA2805656A1 Pharmaceutical composition with enhanced solubility characteristics |
| 01/26/2012 | CA2805612A1 Biodegradable nano-, meso- and micro-polymer particles for maintaining a low surface tension in the lung and for protecting the pulmonary surfactant |
| 01/26/2012 | CA2805430A1 Method for preparing microspheres and microspheres produced thereby |
| 01/26/2012 | CA2804725A1 Pharmaceutical depot for 5- fluoro-2-[[(1s)-1-(5- fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile |
| 01/26/2012 | CA2804032A1 Core-sheath implant device having an inner core lobe |
| 01/26/2012 | CA2803368A1 Ophthalmic devices containing chemokine antagonists |
| 01/25/2012 | EP2410031A1 Base material for spraying comprising low-molecular gelling agent |
| 01/25/2012 | EP2409975A1 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
| 01/25/2012 | EP2409732A1 Compositions and methods for bone formation and remodeling |
| 01/25/2012 | EP2409710A1 Injectable material and material to be used as drug or food supplement for prophylaxis or treatment of osteoporosis |
| 01/25/2012 | EP2409707A1 Polymer-based sustained release device |
| 01/25/2012 | EP2409702A1 Combination of siloxane and active ingredient for treating dental disorder of hard tissues |
| 01/25/2012 | EP2409701A1 Prasugrel granules with improved stability |
| 01/25/2012 | EP2409692A1 Fluid application device and method |
| 01/25/2012 | EP2409691A1 Pharmaceutical cyclosporin compositions |
| 01/25/2012 | EP2409690A2 Improved stability of progestogen formulations |
| 01/25/2012 | EP2409689A1 Prasugrel tablet formulations |
| 01/25/2012 | EP2409688A1 Orally disintegrating tablet |
| 01/25/2012 | EP2409687A1 Water insoluble polymer matrix for drug delivery |
| 01/25/2012 | EP2409686A1 Cell transport compositions and uses thereof |
| 01/25/2012 | EP2409685A2 Orally-disintegrating formulations of prasugrel |
| 01/25/2012 | EP2409683A1 Stable aqueous formulations comprising poorly water soluble active ingredients |
| 01/25/2012 | EP2409676A1 Method for dosing a fluid formulation containing a medicinal substance |
| 01/25/2012 | EP2409651A1 Biological graft transferring instrument and method for transferring biological graft |
| 01/25/2012 | EP2409569A2 Method for administering GLP-1 molecules |
| 01/25/2012 | EP2408821A1 Dynamic bio-nanoparticle elements |
| 01/25/2012 | EP2408493A1 Hazardous agent injection system |
| 01/25/2012 | EP2408453A1 Ophthalmic formulations of cetirizine and methods of use |
| 01/25/2012 | EP2408447A1 Prenylated bisphosphonates as anti-tuberculosis agents |
| 01/25/2012 | EP2408442A1 Pharmaceutical composition presenting anti-inflammatory properties |
| 01/25/2012 | EP2408440A1 Transdermal pharmaceutical preparation and administration of tirofiban |
| 01/25/2012 | EP2408439A1 Bioadhesive patch |
| 01/25/2012 | EP2408438A2 Composite materials loaded with therapeutic and diagnostic agents comprising polymer nanoparticles and polymer fibers |
| 01/25/2012 | EP2408437A1 Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients |
| 01/25/2012 | EP2408436A1 Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients |
| 01/25/2012 | EP2408435A2 Compositions and methods for delivering an agent to a wound |
| 01/25/2012 | EP2408434A1 Treating alzheimer's disease and osteoporosis and reducing aging |
| 01/25/2012 | EP2408433A1 Pharmaceutical composition comprising aliskiren |
| 01/25/2012 | EP2408432A1 Macrocyclic lactone drug delivery system |
| 01/25/2012 | EP2408431A1 Solid retigabine in non-crystalline form |
| 01/25/2012 | EP2408430A1 In situ constituting a vaccine for administration to a predetermined herd of animals |
| 01/25/2012 | EP2408429A2 Preparation for external application |
| 01/25/2012 | EP2408428A2 Germicidal composition |
| 01/25/2012 | EP2408427A1 Galenical formulations of a fixed dose combination of valsartan and aliskiren |
| 01/25/2012 | EP2408426A2 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
| 01/25/2012 | EP2408425A1 Method of creating salt aerosol for breathing by nebulizing an aqueous saline solution |
| 01/25/2012 | EP2408424A2 Dry processing of retigabine |
| 01/25/2012 | EP2408423A2 Zoo-technical drug delivery device |
| 01/25/2012 | EP2299849B1 Fluid bed meal containing a marker and methods of making |
| 01/25/2012 | EP2280688B1 Aqueous pharmaceutical formulation |
| 01/25/2012 | EP2222274B1 Methods and compositons for enhancing the viability of microneedle pores |
| 01/25/2012 | EP2197428B1 Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof |
| 01/25/2012 | EP2150241B1 Sustained release microtablets comprising tolterodine tartrate |
| 01/25/2012 | EP1967188B1 Pharmaceutical preparation of an aqueous solution containing platinum complex |